DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Castro M, Wenzel SE, Bleecker ER. , et al.
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.
Lancet Respir Med 2014;
2 (11) 879-890
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.